FMC Corp. (NYSE: FMC) reported Q4 EPS of $1.12, $0.12 better than the analyst estimate of $1.00. Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.18 million.

Outlook

Pierre Brondeau, FMC president, CEO and chairman, said: "In 2014, the agriculture industry began experiencing a slowdown, particularly in Brazil. Given our leading position in Brazil, this significantly impacted our results. Looking forward to 2015, multiple factors suggest that the crop protection market globally will be, at best, flat to 2014. However, the benefits of Cheminova, especially a more balanced geographic exposure and the ability to realize cost and revenue synergy benefits, will allow FMC to grow segment earnings in Agricultural Solutions between 15 and 30 percent.

"In Health and Nutrition, while we are pleased with the performance in 2014, we believe there are opportunities for improvement by focusing on operational efficiency. Our Manufacturing Excellence programs have demonstrated significant benefits in both Alkali and Lithium, and will be implemented in this segment during 2015.

"The process to sell Alkali Chemicals went very well, and we are pleased with the terms we achieved. In Lithium, we are optimistic that demand for downstream products, particularly for energy storage applications, will continue to grow rapidly. Despite strong underlying performance in our Lithium business, we are unable to produce consistent results across multiple years due to the challenges of operating in Argentina's high-inflation environment.

"2015 is an important year for FMC. In the first part of the year, we will complete the steps we have previously announced in order to position FMC for the future. After we close on the Cheminova and Alkali transactions, we will be in a position to provide additional insights into 2015 and our performance expectations for the next few years."

For earnings history and earnings-related data on FMC Corp. (FMC) click here.